Growth Metrics

Neogen (NEOG) Shares Outstanding (Weighted Average) (2010 - 2026)

Neogen's quarterly Shares Outstanding (Weighted Average) came in at $217.7 million in Q1 2026, little changed year-on-year from $217.0 million in Q1 2025, and little changed quarter-over-quarter from $217.4 million in Q4 2025.

Neogen has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $217.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.31% year-over-year to $217.7 million; the trailing twelve-month figure through Feb 2026 stood at $217.7 million (changed 0.31% YoY), and the FY2025 full-year result was $216.9 million, changed 0.19% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $217.7 million, roughly flat from $217.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $217.7 million in Q1 2026, with the low at $107.7 million in Q2 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $195.9 million, with a median of $216.5 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Weighted Average) surged 100.79% in 2022 and advanced 0.1% in 2023.
  • Tracing NEOG's Shares Outstanding (Weighted Average) over 5 years: stood at $216.1 million in 2022, then advanced by 0.1% to $216.4 million in 2023, then rose by 0.21% to $216.8 million in 2024, then increased by 0.27% to $217.4 million in 2025, then climbed by 0.12% to $217.7 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $217.7 million (Q1 2026), $217.4 million (Q4 2025), and $217.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.74 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 382.90 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 456.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 98.20 Mn
10 Neogen 1.94 Bn 1.78 Bn 99.00 Mn 217.67 Mn

Historic Data

Download Data 🔒
DateValue
Feb 28, 2026 217.67 Mn
Nov 30, 2025 217.41 Mn
Aug 31, 2025 217.22 Mn
May 31, 2025 216.89 Mn
Feb 28, 2025 217.00 Mn
Nov 30, 2024 216.81 Mn
Aug 31, 2024 216.70 Mn
May 31, 2024 216.48 Mn
Feb 29, 2024 216.60 Mn
Nov 30, 2023 216.36 Mn
Aug 31, 2023 216.31 Mn
May 31, 2023 188.88 Mn
Feb 28, 2023 216.22 Mn
Nov 30, 2022 216.13 Mn
Aug 31, 2022 107.84 Mn
May 31, 2022 107.68 Mn
Feb 28, 2022 107.82 Mn
Nov 30, 2021 107.64 Mn
Aug 31, 2021 107.49 Mn
May 31, 2021 106.50 Mn
Feb 28, 2021 106.26 Mn
Nov 30, 2020 106.04 Mn
Aug 31, 2020 105.98 Mn
May 31, 2020 105.10 Mn
Feb 29, 2020 52.46 Mn
Nov 30, 2019 52.36 Mn
Aug 31, 2019 52.29 Mn
May 31, 2019 103.78 Mn
Feb 28, 2019 52.07 Mn
Nov 30, 2018 52.02 Mn
Aug 31, 2018 51.81 Mn
May 31, 2018 51.36 Mn
Feb 28, 2018 51.54 Mn
Nov 30, 2017 51.11 Mn
Aug 31, 2017 50.95 Mn
May 31, 2017 50.54 Mn
Feb 28, 2017 50.44 Mn
Nov 30, 2016 50.29 Mn
Aug 31, 2016 37.62 Mn
May 31, 2016 49.87 Mn
Feb 29, 2016 37.36 Mn
Nov 30, 2015 37.30 Mn
Aug 31, 2015 37.21 Mn
May 31, 2015 36.95 Mn
Feb 28, 2015 37.01 Mn
Nov 30, 2014 36.94 Mn
Aug 31, 2014 36.78 Mn
May 31, 2014 36.51 Mn
Feb 28, 2014 36.47 Mn
Nov 30, 2013 36.46 Mn
Aug 31, 2013 36.16 Mn
May 31, 2013 35.77 Mn
Feb 28, 2013 35.84 Mn
Nov 30, 2012 35.63 Mn
Aug 31, 2012 23.68 Mn
May 31, 2012 35.20 Mn
Feb 29, 2012 23.54 Mn
Nov 30, 2011 23.42 Mn
Aug 31, 2011 23.33 Mn
May 31, 2011 23.01 Mn
Feb 28, 2011 22.92 Mn
Nov 30, 2010 22.80 Mn
Aug 31, 2010 22.68 Mn
May 31, 2010 22.43 Mn